Edgewell Personal Care CompanyEPCNYSE
Loading
R&D Expenses Over TimeStable
Percentile Rank21
3Y CAGR+1.2%
5Y CAGR+0.8%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+1.2%/yr
vs -2.4%/yr prior
5Y CAGR
+0.8%/yr
Consistent
Acceleration
+3.6pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
2025$57.60M-1.4%
2024$58.40M-0.2%
2023$58.50M+5.4%
2022$55.50M-4.0%
2021$57.80M+4.5%
2020$55.30M+3.4%
2019$53.50M-12.4%
2018$61.10M-9.6%
2017$67.60M-6.0%
2016$71.90M-